Medtronic’s new software to enhance efficiency of targeted drug delivery for clinicians

Medtronic announced the US launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal drug delivery system, which is due to be released in Australia and New Zealand later this year.

The Efficio management software will allow clinicians to more efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer pain and severe spasticity. The cloud-based data management software provides enhanced, secure access to patient data and delivers actionable insights for clinicians.

“For years, clinicians have been managing pump patients on their own with internal spreadsheets and other manual processes,” said Chris Beuer, M.D., director of pain management at Christian Hospital in St. Louis, Mo., who was involved with the pilot program. “Now, with the click of a button, I can understand the dosing history of an individual patient or produce end-of-day reports within minutes. Efficio also helps me manage pump refill dates, pump replacements, and monitor trends in dosing and patient function. It provides tremendous value to my practice, allowing me to focus more time caring for my patients.”

Enhance corporate branding and boost thought leadership to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our proven digital media solutions developed by industry for industry.

“Efficio marks another step in our journey to simplify targeted drug delivery therapy,” said Charlie Covert, vice president and general manager of the Targeted Drug Delivery business, which is part of the Restorative Therapies Group at Medtronic. “We believe providing innovative solutions that simplify management of the therapy will enable clinicians to reduce pain or severe spasticity symptoms for even more patients with this proven therapy.”

Efficio software is designed to safeguard protected health information. Data is protected using encryption and authentication. Access restrictions and login time limits are also in place to help protect data.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

You may also like MTAA’s landmark agreement delivers medical device savings for millions of Australians